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Abstract
Vitamins are essential micronutrients for normal development. Great
emphasis has been placed on vitamin D for bone development and maintenance.
However, other vitamins also influence bone health. While some of them are
more beneficial to bone and increase bone mass by increasing bone formation,
calcium deposition and stimulate osteoblastogenesis, higher concentrations of
others have deleterious effects causing fragile bones and increasing the risk
of fractures. Knowledge about the effects of these vitamins will help in better
maintenance of bone. This review focuses on the information available on
vitamins A,B,C,E and K on bone health. Existing information supports vitamin
C and K to play a role in bone formation and calcification. Vitamin E in low
amounts and some of the B vitamins may also be beneficial to bone. There is
very limited data supporting the favorable effects of vitamin A.
Keywords: Vitamin A; Vitamin B; Vitamin C; Vitamin E; Vitamin K; Bone

Abbreviations
ALP: Alkaline Phosphatase; αTF: α tocopherol; BMC: Bone
Mineral Content; BMD: Bone Mineral Density; BMP: Bone
Morphogenetic Protein; COX2: Cyclooxygenase 2; FN: Femoral Neck;
G-CSF: Granulocyte Colony Stimulating Factor; IGF-I: Insulin Like
Growth Factor I; IL: Interleukin; MTHFR: Methylenetetrahydrofolate
reductase; NFAT: Nuclear Factor Activated T Cells; OVX:
Ovariectomized; PTH: Parathyroid Hormone; PPAR: Peroxisome
Proliferator-Activated Receptor; PGE: Prostaglandin E; PUFA:
Polyunsaturated Fatty Acid; RAR: Retinoic Acid Receptor; RXR:
Retinoid X Receptor; RA: Retinoic Acid; RANKL: Receptor Activated
Nuclear Factor Kappa Ligand; SVCT: Sodium Dependent Vitamin
C Transporter; IEC-6: Small Intestine Epithelial Cells; SD: Sprague
Dawley; TGF: Tumor Growth Factor; TRAP: Tartrateresistant Acid
Phosphatase

Introduction
An individual’s well-being is dependent on several factors such
as: diet, physical activity, availability of resources etc. Among diet, the
balance in intake of macronutrients such as carbohydrates, proteins,
lipids and micronutrients like vitamins and minerals is important.
Vitamins form some of the most essential micronutrients. They are
implicated in many diseases that can be reversed by supplementing
or limiting the intake of vitamins.
Vitamins are divided into water soluble (B vitamins, C) or fat
soluble (vitamins A, D, E, K) depending on their solubility. Their
categorization also refers to the mode by which they are absorbed in
the body after digestion. Water soluble vitamins are absorbed with
the help of sodium dependent transporters, while fat soluble vitamins
follow the fat absorption pathway and are packed in chylomicrons for
delivery to the organs. The availability and storage of these vitamins is
dependent on ones intake. They serve as important catalyst for many
enzymatic activities; are converted to essential compounds required
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for normal metabolism or they can activate and deactivate important
signaling pathways. Therefore, adequate vitamin intake is necessary
for normal development of all the different organ systems, in an
individual, including the skeletal system.
Bone is an active organ undergoing modeling and remodeling
throughout life. During childhood and adolescence, bone modeling
takes place helping the bones to grow. Throughout this period, bone
formation is dominant and needs balanced nutrients to increase
bone mass. After attaining peak bone mass, the skeletal system is
maintained by bone remodeling and bone resorption increases,
steadily decreasing bone mass with age. Several vitamins play a
role in building bones and maintaining them through the years. An
imbalance or decrease intake of these vitamins can negatively impact
the bone remodeling process by increasing bone resorption. When
bones do not get the nourishment required for normal growth and
development, they are weak and are easily susceptible to fractures
putting individuals at risk of developing osteoporosis. Osteoporosis is
a medical condition that is seen in one out of two women and one out
of four men [1]. People diagnosed with osteoporosis have low bone
mass and fragile bones that breaks with minor trauma. In women,
bone loss is accelerated during menopause and post menopause.
However, close to half the trabecular bone is lost in women and men
before the age of 50 [2].
Bone formation and resorption are sequestered events involving
many different proteins. Bone formation is accomplished by
osteoblasts. Osteoblasts differentiate from bone marrow stem
cells (mesenchymal stem cells) under the influence of growth
factors(insulin-like growth factor I (IGF-I)), cytokines (Interleukin
(IL) -18 (IL-18)), several transcriptional regulators (homeodomain
proteins, surfactant proteins, Runt homology domain transcriptional
factors), hormones (estrogen, parathyroid hormone (PTH), vitamin
D), prostaglandin E1 (PGE1), on costatin M, adrenomedullin and
leptin [3]. Mature osteoblasts first form the collagen matrix and then

Citation: Salazar RE and Banu J. An Insight into the Role of Vitamins other than Vitamin D on Bone. Austin J
Nutr Metab. 2015; 2(3): 1024.

Banu J

Austin Publishing Group

Table 1: Sources of the various vitamin B compounds [7-9].
Vitamin

Source

Found in cereals (rice, wheat, maida, rava, poha, etc.) breads, fortified cereals and pasta, pulses or lentils (dals such as moong dal, masoor
dal, chana dal etc), legumes (whole pulses such as whole moong, channa, chowli, rajmah), dark green leafy vegetables such as spinach,
Vitamin B1 (Thiamine)
fenugreek, lettuce, cabbage, asparagus etc. soy foods, whole grains like wheat germ, fish, egg, milk, meat, pork ham etc, nuts such as
almonds and pecans. Daily value: 1mg for men; 0.8mg for women.
Some of the best sources of riboflavin are chicken, fish, eggs, legumes (like peas and lentils), milk and milk products such as yogurt and
Vitamin B2 (Riboflavin)
cheese, nuts, green leafy vegetables like spinach, broccoli, asparagus, and fortified cereals also supply significant amounts of riboflavin to
the diet. Daily value: 1.3mg for men; 1.1mg for women.
It is found in chicken, salmon and in fishes like canned tuna – they are an excellent source of niacin. Vegetarians can get their source of
Vitamin B3 (Niacin)
niacin from legumes, pasta and whole wheat. Daily value: 17mg for men; 13mg for women.
Foods like potatoes, beans, red meat, poultry, eggs and fortified cereals contain are very high in vitamin B6. Daily value: 1.4mg for men;
Vitamin B6 (Pyridoxine)
1.2mg for women.
Yogurt and avocado are both excellent sources of pantothenic acid, but it is also available in a wide variety of foods such as legumes
Vitamin B5
(Pantothenic Acid)
including lentils and split peas, sweet potatoes, mushrooms and broccoli. Daily Value: 4-7 mg for adults.
Liver and egg yolks are the richest dietary sources of biotin, but fortunately this B vitamin is well distributed throughout the food supply, so it
is doubtful that anyone eating a balanced, varied diet will experience a deficiency. Salmon, pork and avocado are good sources; most fruits
Vitamin B7 (Biotin)
and vegetables contain a little biotin, as do cheeses and grain foods. Daily value: 30-100 mg for adolescents and adults.
To remember which foods are high in folate, remember that the word folate has the same root as the word foliage. Leafy greens such as
Vitamin B9 (Folate, folic
spinach, fenugreek, turnip greens, asparagus, etc and other fresh fruits and vegetables are all excellent sources of folate. Liver, dried
acid, or folacin)
beans and other legumes, and orange juice are good sources of this vitamin. So are fortified bread, rice, and cereals. Daily value: 0.2mg for
adults.
Animal foods are the only natural source of vitamin B12. It is found naturally in fish, red meat, poultry, milk, milk products, cheese, and
Vitamin B12
(Cobalamin)
eggs. But, many products, including soy products and cereals, are fortified with B12 so it is widely available in the food supply. Other good
natural sources include shellfish, such as clams, mussels and crab, fin fish and beef. Daily value: 0.0015mg for adults.

with the help of osteocalcin start the mineralization process [3]. On
the other hand, cells involved in bone resorption, are multinucleated
cells called osteoclasts and differentiate from hematopoietic cells.
Their differentiation takes place under the influence of several
cytokines (IL-1, IL-6, IL-7, and tumor necrosis factor-α (TNFα),
hormones (PTH, estrogen and vitamin D) and prostaglandin E2
(PGE2). These cells, dissolve the matrix proteins [4] and release the
minerals from the bone leading to cavities and increasing the fragility
of the bone [3].
This review focuses on the influence of vitamins on bone health.
Articles were collected from Pubmed and Medline databases. The
keywords used were: vitamin A and bone, retinoic acid (RA) and bone,
vitamin B and bone, thiamine and bone, riboflavin and bone, vitamin
B3 and bone, vitamin B5 and bone, vitamin B6 and bone, vitamin B7
and bone, vitamin B9 and bone, vitamin B12 and bone, vitamin C and
bone, vitamin E and bone, and vitamin K and bone. As the role of
vitamin D on bone health is very well established, this review focuses
on the influence of other vitamins on bone strength, bone mineral
density (BMD), micro architecture and pathways of bone.

Water Soluble Vitamins
There are two water soluble vitamins – vitamin B complex and
vitamin C. Both vitamin B complex and C are not stored in the body
and have to be supplemented in the diet regularly. They are absorbed
with the help of sodium dependent transporters [5].
Vitamin B complex
B Vitamins are composed of 8 compounds: vitamin B1 (thiamine),
vitamin B2 (riboflavin), vitamin B3 (niacin), vitamin B5 (pantothenic
acids), vitamin B6 (pyridoxine, pyridoxal, pyridoxamine), vitamin
B7 (biotin), vitamin B9 (folic acid), vitamin B12 (cobalamine) [5]. Off
these, thiamine prevented malformations of the palate related to
teratogony [6]. Studies on the direct effects of thiamine on bone are
lacking. Sources of the different B vitamin are listed in Table 1 [7-9].
In vitro studies using Vitamin B2 (riboflavin) in MC3T3 cells,
which can be differentiated to become osteoblasts, have shown to
Submit your Manuscript | www.austinpublishinggroup.com

enhance the differentiation process [10]. Osteoclastogenesis was also
decreased by riboflavin through the expression of osteoprotegrin
which is secreted by the osteoblastic stromal cells [10]. In patients
with elevated homocysteine, due to MTHFR C677T polymorphism,
riboflavin was not associated with fracture risk [11] especially in the
femoral neck [12].
In vitro studies using vitamin B3 (niacin and niacin amide) have
shown no effect on the bone mineral content (BMC) in male leghorn
chicken, and it also decreased bone strength [13,14]. This may be
because niacin can stimulate oxidative stress in bone marrow cells
[15] – a factor that stimulates bone resorption. However, in diabetic
mice, niacin supplementation improved blood flow after ischemia
[16] which may be beneficial to bone health.
Limited studies have reported the effects of vitamin B5
(pantothenic acid) on bone. Deficiency of this vitamin changed the
osteogenesis in the tibia of rats, in a time dependent manner. Reports
concluded that, longer deficiency caused more damage to the tibia
[17,18]. Additionally, longer periods of pantothenic acid deficiency,
led to decreased osteoblast proliferation, osteogenesis and increased
trabecular bone resorption which led to loss of trabeculae [17].
The effects of vitamin B6 (pyridoxine, pyridoxal and
pyridoxamine), on bone health, has been reported in a few in
vivo studies. Studies on male Wister rats showed that vitamin B6
deficiency decreased cross-link intermediates and impaired crosslink
formation [19]. Similar effects were also reported in chick embryo.
When treated with vitamin B6 antagonist there was decreased crosslinking of collagen supporting vitamin B6 supplementation during
pregnancy [20]. In addition, vitamin B6 deficiency decreased alkaline
phosphatase (ALP), bone healing and tibial strength [21].
Vitamin B7 (biotin) deficiency affects bone formation. In broiler
chicken, vitamin B7 deficiency decreased periosteal bone apposition,
bone formation rate, osteoid perimeter and IGF-I [22,23]. Biotin may
require riboflavin to maintain tibial BMD, strength and stiffness as
demonstrated in young turkey chicks [24].
Vitamin B9 (folic acid and folate) is well known for their effects on
Austin J Nutr Metab 2(3): id1024 (2015) - Page - 02
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Table 2: List of sources, serving size, and vitamin C content in foods [7-9].
Source

Serving Size

Vitamin Content (mg)

Guava, raw

½ cup

188

Red sweet pepper, raw

½ cup

142

Red Sweet pepper, cooked

½ cup

116

Kiwi fruit

1 medium

70

Orange, raw

1 medium

70

Orange juice, ¾ cup

¾ cup

61-93

Green pepper, sweet, raw

½ cup

60

Green pepper, sweet, cooked

½ cup

51

Grapefruit juice

¾ cup

50-70

Vegetable juice cocktail

¾ cup

50

Strawberries, raw

½ cup

49

Brussel sprouts, cooked

½ cup

48

Cantaloupe

¼ medium

47

Papaya, raw

¼ medium

47

Kohlrabi, cooked

½ cup

45

Daily value: 90 mg for men; 75 mg for women

the nervous system. In the rat embryo skull bone, folic acid decreased
TGFβ1 and TGF-1 expression [25]. Otherwise, there is no evidence
that folic acid directly affects bone. However, when adequate amount
of folate is not consumed, there is decreased BMD and trabecular
thickness in the vertebra of postmenopausal women which can be
reversed with folate supplementation [26,27]. Additional studies,
showed that folic acid could reduce the accumulation of aluminum in
organs such as bone, kidney and brain, thereby, reducing the toxicity
[28].
Vitamin B12 (cobalamine) can act on both osteoblasts and
osteoclasts [29-31]. Its deficiency decreased bone mass by stimulating
osteoclastogenesis mainly by increasing methyl malonic acid and
homocysteine [29]. It also influenced ALP secretion in patients’
deficient with vitamin B12 and decreased BMD [30-34]. In vegetarians
decreased intake of vitamin B12 increased bone turnover [35] which
may lead to net loss of bone.
Decreased consumption of vitamin B12 and folic acid decreased
BMD in older men which led to greater bone loss [26,36,37]. One
of the functions of vitamin B12 and B6 is to regulate homocysteine.
Hyperhomocysteinemia is caused by deficiency of folate and B12 [38].
For every mmol/l of homocysteine there is 4% increase in fracture
risk [32,39]. Universally, homocysteine is associated inversely with
BMD, as it reduced BMD in older women [33,40-44]. Increased
homocysteine and low vitamin B12 were significantly associated with
high levels of bone turnover markers and increased fracture risk
[45]. High concentrations of homocysteine may also interfere with
the cross linking of collagen, thereby, decreasing the stability and
strength of collagen network [46]. Additional evidence showed that
homocysteine may increase osteoclast formation and activity [4648], bone turnover [44] and bone marker levels [44]. Due to plasma
homocysteine levels association with osteoporosis [49], it has been
suggested that levels of circulating homocysteine can be used as
a marker of fragility in females>75 years of age [44]. In male rats,
Submit your Manuscript | www.austinpublishinggroup.com

however, there was no change in the BMD in the tibia, although
there was decreased blood flow to the bone and reduced biochemical
properties [50]. Homocysteine is reported to bind with collagen
resulting in decreased bone strength [32,51]. Supplementation
with folic acid, vitamins B12 and vitamin B6 effectively reduced
homocysteine levels [46].
Except for vitamin B3, other vitamin B compounds are beneficial
to bone health. It was interesting to note that there were scanty
reports on vitamin B1 and bone. Vitamin B12 and B6 plays a major role
in lowering homocysteine levels, thereby reducing osteoclast activity
and decreasing bone turnover.
Vitamins C (ascorbic acid)
Vitamin C is absorbed in the small intestine into the brush border
cells using the sodium dependent vitamin C transporter (SVCT)
proteins. When this transporter is overexpressed, it is able to increase
mineralization and calcium deposition. It is also reported to help
with the bone marrow stromal cells to differentiate into osteoblasts
as knockdown of this transporter inhibitedosteogenesisin these cells
[52]. In bone marrow aspirates from athymic BALB/C ru mice with
subcutaneous implant, ALP and calcium deposition on scaffolds
increased [53] with vitamin C supplementation. A list of the sources,
serving sizes and recommended daily value of vitamin C is given in
Table 2 [7,9].
In male Sprague Dawley (SD) rats, there was increased
bioavailability of calcium as corbate compared to calcium acetate [54].
In female guinea pigs, lower intake of vitamin C was associated with
decreased collagen synthesis resulting in lower levels of collagen, ALP
and osteocalcin [55,56]. Decreased intake of vitamin C also increased
bone turnover and reduced transition of salts to the crystalline form
[57], whereas, long term deficiency of vitamin C, decreased skeletal
maturation and showed bone abnormalities in female guinea pigs
[58]. Total deprivation of vitamin C in guinea pigs led to destruction
of the proximal tibia with micro fractures. Additionally, damage to
the diaphysis led to Genu Varums (bow legs) [59]. Treatment with
vitamin C restored the tibia and formation of trabecular bone at the
growth cartilage by sub periosteal thickening [59] and development
of trabecular callus. However in dogs, vitamin C supplementation
did not modify BMC [60] and the tibial breaking strength or
egg shell thickness in hens also was not altered due to vitamin C
supplementation [61]. Inversely, in chicks, it is reported that ascorbic
acid may be involved in mobilizing calcium and phosphorus soon
after injection but had no effect on bone resorption or the bone
formation process [62].
Vitamin C deficiency accelerated bone loss and increased
fractures, in the femur of senescence marker protein 30 knockout
mice [63]. It is known to help in the differentiation of osteoblasts and
deficiency promotes osteoblasts to transition into adipocytes [63].
It may accomplish this by upregulating the expression of proximal
proliferator-activated receptor gamma (PPARγ) [63] which is an
important cofactor required for the hydroxylation of collagen and
is necessary for osteoblast proliferation [64]. ALP expression is also
dependent on as corbate levels. It influenced collagen organization
to form the protein matrix for the deposition of minerals [64].
In addition, it is established that vitamin C deficiency inhibits
calcification process [64].
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Table 3: List of sources, serving size, and vitamin A content in foods [7-9].
Vitamin Content
Sources
Serving Size
(IU)
Liver, beef, cooked*

3 oz.

27,185

Liver, chicken, cooked*

3 oz.

12,325

Carrot juice, canned*

½ cup

22,567

Carrots, boiled*

½ cup slices

13,418

Spinach, frozen, boiled*

½ cup

11,458

Kale, frozen, boiled

½ cup

9558

Carrots, raw

7 ½ in

8666

Vegetable soup, canned, chunky, readyto-serve

1 cup

5820

Cantaloupe

1 cup cubes

5411

Spinach, raw

1 cup

2813

Apricots with skin, juice pack

½ cup

2063

Daily value: 5000IU for adults and children age 4 and older
*high in retinol activity equivalents.

In postmenopausal women, BMD decreased in response to lower
vitamin C intake in a dose dependent manner, however, there was
no such effect in males [65]. Another study reported a 3% increase
in BMD at the ultra-distalmidshaft, radii, hip and lumbar spine in
postmenopausal women [66]. It also increased ALP and enhanced
collagen synthesis as well as stimulated procollagen [66]. Short
term (7 weeks) vitamin C supplementation in children (boys) did
not show any changes in biochemical markers like pyridoxiline and
deoxypyridoxiline [67].
Fluoride toxicity in monkeys and copper toxicity in rabbits were
attenuated by supplementation with vitamin C [68,69]. Vitamin C
and Zinc positively influenced bone geometry, size and strength in
children [70].
Overall, vitamin C is required for osteoblast differentiation and
is important for bone formation. It is also an anti-oxidant, therefore,
may act by reducing oxidative stress and positively influencing bone.

Fat Soluble Vitamins
All fat soluble vitamins are absorbed along with fatty acid and
delivered to the liver as fatty acid. It is dependent on bile salts and can
be transported in chylomicrons. These vitamins are stored in the body
just like fatty acids.
Vitamin A (retinoids)
Vitamin A consists of a group of compounds – retinal, retinyl
ester, retinol and RA [5]. Vitamin A can affect the translational
processes in cells and nuclear receptors like retinoic acid receptor
(RAR) and retinoid X receptor (RXR) help in this process. The
sources, serving sizes and recommended intake of vitamin A and pro
vitamin A are listed in Table 3 [7,9].
RA treatment of growth plate chondrocytes, induced annexins II,
V and VI to form Ca2+ channels and influx calcium into the cells. It
also stimulated the release of ALP to initiate mineralization [71]. In
addition, RA stimulated chondrocyte differentiation by upregulating
the expression of bone morphogenetic protein (BMP) [72]. In human
and murine cells, RA inhibited Receptor Activator of Nuclear Factor
kappa-B Ligand (RANΚL) stimulated osteoclast differentiation [73]
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and in the fish, Atlantic cod, RA decreased bone resorption [74].
On the other hand, there are also reports that RA decreased BMP2
expression thereby stimulating osteoclastogenesis [75] and induced
bone loss. Interestingly, it has been used as a method to induce bone
loss in female rats [76]. There are also reports showing reduction of
mineralization with RA supplementation [77] and RA has a negative
effect on the oral bone mass in rats [78].
One of the receptors, retinoic acid receptor γ (RARγ) is a potent
inhibitor of osteoclastogenesis as it decreased nuclear factor activated
T cells (NFAT) activation, granulocyte colony stimulating factor
(G-CSF) and RANKL, and also increased bone formation [79].
Carotenoids from fruits and vegetables act through the anti-oxidant
pathway to reduce bone resorption [80].
Vitamin A supplementation in female rats, increased BMD
but decreased trabecular area with no change in cortical thickness
or stiffness and levels of osteocalcin [81]. In IEC-6 cells, vitamin A
supplementation up regulated ALP [82]. Vitamin A can also promote
bone formation through the BMP2/7 heterodimer [83]. It is also
reported that vitamin A supplementation in postmenopausal women,
had no age related increase in risk for fractures or any changes in
BMD [84] and the mechanical properties of the bone [85]. However,
the beneficial effect of vitamin A is more in the trabecular bone than
the cortical bone in aged rats [85]. When vitamin A is consumed with
polyunsaturated fatty acids (PUFAs) they act on different pathways
and while vitamin A can cause malformations, PUFAs increased bone
formation independent of each other [86].
However, some reports concluded that supplementation with
vitamin A did not show any beneficial or detrimental effects in
humans and animal models. In women, decreased intake of vitamin A
did not have a detrimental effect on bone [84] and in men, short term
supplementation with vitamin A did not influence bone turnover
[87]. Similarly, studies on dogs supplemented with vitamin A also did
not show any detrimental effects on bone [88].
Another vitamin A compound, retinol has a negative effect on
bone as it decreased BMD in mice and rats [89-94]. Increased intake
of retinol increased bone fragility and fracture risk at different sites
including the femur neck, Ward’s triangle, trochanter region of
the proximal femur, lumbar spine [93,95]. In cases where there is
decreased vitamin D, increased intake of retinol further increased
fracture risk [96]. However, retinol with retinol binding protein 4
showed decreased osteoclast activity in humans (males) [97]. Early
studies have shown that decreased vitamin A increased osteoblast
activity [98].
In addition, there are studies that have reported several negative
effects on bone, especially when vitamin A was given to children.
Problems reported include building of fontanelle, increase in
intracranial pressure, anoxia, drowsiness, instability followed by
brain damage [99,100]. Dhem et al. have reported several other
detrimental effects of vitamin A supplementation including lesions in
the endocortical surface of the tibia, cavities and demineralization on
the periosteal surface and cancellous bone, enlargement of Haversian
canals [77,91,101] and hypervitaminosis A which is associated with
long bone fractures [77,91]. High intake of cod liver oil also increased
the risk of fractures [102].
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Table 4: List of sources, serving sizes, and Vitamin E content in foods [7-9].

Table 5: List of sources, serving sizes, and Vitamin K content in foods [7-9].

Source

Serving Size

Vitamin Content (mg)

Source

Serving Size

Vitamin Content (cg)

Sunflower seeds, dry roasted

1 oz.

7.4

Brussel sprouts

½ cup

460

Sunflower oil, high linoleic

1 Tbsp.

5.6

Turnips greens, raw, chopped

1 cup

364

Cottonseed oil

1 Tbsp.

4.8

Broccoli

½ cup

248

Safflower oil, high oleic

1 Tbsp.

4.6

Lentils, dry

½ cup

214

Hazelnuts (filberts)

1 oz.

4.3

Cauliflower

½ cup

150

Mixed nuts, dry roasted

1 oz.

3.1

Kale, cooked

½ cup

150

Turnip greens, frozen, cooked

½ cup

2.9

Spinach, raw, chopped

½ cup

149

Tomato paste

¼ cup

2.8

Garbanzo beans, dry

½ cup

132

Pine nuts

1 oz.

2.6

Swiss chard

½ cup

124

Peanut butter

2 Tbsp.

2.5

Daily value: 75µg for men and women

Tomato Puree

½ cup

2.5

Tomato sauce

½ cup

2.5

Canola oil

1 Tbsp.

2.4

Wheat germ, toasted, plain

2 Tbsp.

2.3

improve calcium in the bone [114]. The beneficial effects of vitamin E
are attributed to the tocotrienols in the vitamin E mixture used in the
study. The ratio of vitamin E to lipids is significantly associated with
decreased BMD of the lumbar spine of in postmenopausal women
[115,116]. Moreover, αTF may modulate γTF by reducing its levels
and affect bone formation [115].

Daily value: 30IU for adults and children above age 4.

Although vitamin A has shown some bone protective effects by
up-regulating BMP, and RAR inhibited osteoclastogenesis, there are
many reports indicating that consuming high levels of this vitamin
may be deleterious to both long and parietal bones.

In lower concentrations, αTF can protect bone and at high
concentrations is detrimental to bone as they can interfere with the
function of vitamin K and other isoforms of vitamin E [117-119].
Moreover, the source of vitamin E may also make a difference [109].

Vitamin E (tocopherols)

Vitamin K

Vitamin E consists of the tocopherols and tocotrienols. Each of
them include4 vitamers but α tocopherol (αTF) is the biologically
active form and has been studied very extensively. Table 4 lists the
sources, caloric content with the recommended daily value intake of
vitamin E [7,9].

Vitamin K includes two compounds – vitamin K1 (Phylloquinone)
and K2 (Menaquinone). The major function of vitamin K is to
promote coagulation of blood but recently there is evidence that it
is also involved in maintaining bone health [120,121] by increasing
bone formation and reducing bone resorption [122]. Table 5 has the
list of sources and serving size with the daily value for vitamin K [7,9].

Vitamin E levels have been directly related to the bone status
in humans as osteoporotic subjects have less circulating vitamin
E levels [103,104]. Many in vivo studies have reported the benefits
of αTF. Supplementation with αTF increased mineralizing surface,
bone formation rates and strength of bones in OVX rats [105,106].
In addition, it also decreased osteoclast surface at medium dose
as well as in low doses and reduced oxidative stress [107-109]. In
postmenopausal rat model, trabecular bone volume, trabecular
number increased and trabecular separation decreased with
αTF supplementation [106,107]. Biochemical markers like ALP,
osteocalcin and IGF-I expression increased with αTF [108,110] and
decreased TRAP. In male rats αTF prevented bone loss due to disuse
of hind limb by decreasing cyclooxygenase – 2 (COX-2) [111]. Older
mice showed increased yield stress, ultimate load and stiffness of
bone [110], however this effect was not seen in younger mice with
αTF supplementation. However, the effect of vitamin E is site specific
as it positively correlates with BMD in the spine and not in the long
bones [112]. Young (6 months old) and old (24 months old) C57Bl/6
mice when fed vitamin E showed increased bone strength and matrix
protein with no change in BMD. This effect was more in older mice
than younger mice. There was also decreased PGE2 and increased
IGF-I formation [110]. In female rats, vitamin E also increased
calcium content [113] and also increased calcium availability and
decreased certain free radical production; however, αTF did not
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Vitamin K is implicated in carboxylating a couple of proteins
that are involved in the bone formation process - matrix Gla proteins
and osteocalcin [123-125]. Matrix Gla protein has high affinity to
calcium and functions as a modulator of calcium availability [126].
Osteocalcin is a protein secreted by osteoblasts and is an important
bone biochemical marker associated with increase in bone formation
[127-129]. Age related decrease in γ carboxylation of osteocalcin
takes place [130].
Several studies have shown that osteocalcin is under carboxylated
and does not mobilize the calcium for mineralization, thereby,
decreasing bone formation and vitamin K supplementation
attenuated this effect by carboxylating osteocalcin [131,132],
therefore, is beneficial to bone [133].
Many in vivo studies on animal models have shown the
benefits of vitamin K supplementation. Male rats, supplemented
with menaquinone, showed decreased under carboxylated
osteocalcinalong with increased mineral crystallinity and hardness
in the tibiae [134]. OVX rats, fed vitamin K, showed higher bone
strength and decreased risk of fractures in the tibia and femur by
increasing trabecular bone volume [135,136] trabecular number and
decreasing trabecular separation, osteoclast number/bone surface and
osteoclast surface/bone surface [137]. Vitamin K also promoted bone
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healing in a rodent model of osteotomy [138]. In gastroectomized
SD rats, vitamin K2 supplementation attenuated the decrease in
ultimate force and increased stiffness of the femoral diaphysis [139].
Male orchidectomized rats, showed increased bone MAR, BFR, BV/
TV and BV [140-142] and improved trabecular micro architecture
with vitamin K supplementation [132]. Similar benefits of vitamin K
supplementation on the trabecular structure and bone volume in tail
suspended rats [143] was also reported.
Children with better vitamin K status had increased bone mass
[144]. In early menopausal women, under caroboxylated osteocalcin
was negatively associated with BMD in the total hip, femoral neck,
and lumbar spine [145,146]. Elderly institutionalized men and
women are recommended to consume higher amounts of vitamin
K than the recommended adequate intake to maintain skeletal
health [147]. In healthy postmenopausal women, supplementation
of vitamin K2, significantly, decreased loss in vertebral height and
increased bone strength, BMC and BMD in the lumbar spine, femoral
neck and hip bone geometry [148-151]. Biochemical markers of bone
metabolism like serum under carboxylated osteocalcin decreased and
γ carboxylated osteocalcin increased, with vitamin K supplementation
[152,153]. Healthy women in the ages of 30-88 years showed decreased
under carboxylated osteocalcin especially in older women, among the
cohort studied [154]. However, another study reported decreased
bone turnover in both the young and elderly, when supplemented
with vitamin K [155]. A direct relationship between BMD and lower
concentrations of phylloquinone in postmenopausal women was also
reported [156]. Plasma phylloquinone levels were inversely associated
with N- terminal telopeptide and under carboxylated osteocalcin
in girls (3-16 years of age) [157]. Interestingly, decreased vitamin K
intake decreased BMD in female but not in males [158]. Vitamin K
also induced IL-1α, PGE2 [159] in patients with femur neck fractures
or lower BMD had decreased levels of circulating vitamin K [160,161].
Vitamin K supplementation also protected bone by modulating bone
turnover during space flight [162] and osteoporotic patients with
vitamin K2 supplementation showed increased lumbar BMD [163].
Vitamin K when supplemented with alendronate increased total
and trabecular BMD at the distal metaphysis of the femur, in mice. It
also increased the strength of the bone [164]. Combined treatment
with risendronate and vitamin K prevented glucocorticoid induced
bone loss and decreased bone formation and bone erosion in rats
[165-167]. In addition, when OVX rats were given vitamin K in
combination with bisphosphonates, pretreatment with vitamin K
improved the strength, BMD, BMC and trabecular structure in the
femur [168,169]. OVX rats with, vitamin K2 and Raloxifene showed
greater strength in the femoral neck [170]. Vitamin K supplementation
may also reduce drug induced osteoporosis [155].
Although there are many studies showing the benefits of vitamin
K on bone, there are some studies that did not show any benefits.
Early menopausal women did not show any benefits with vitamin
K supplementation for 1 year [171]. Six months of vitamin K
supplementation did not show any significant increase in BMD in
pre and perimenopausal women [172]. In OVX rats, vitamin K did
not change the BMD in the distal femur [173]. This may be due to the
short term treatment or the concentration of vitamin K given to the
subjects or there might have been drug/nutrient interactions.
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Figure 1: Text Here.

There is ample evidence to show that vitamin K is essential for the
carboxylation of osteocalcin and improves calcium deposition in the
matrix. Therefore, adequate vitamin K is necessary to maintain the
mineral content and strength in bones.

Combination of Vitamins on Bone
Combination of vitamins C and E partially prevented bone
destruction due to heparin [174]. αTF interacts with vitamin K and
other vitamin E isomers to increase pro-oxidative effects. Vitamin D
and K may have synergistic effects [175-177]. Decreased vitamin E
and C increased fracture risk in smokers [95,103]. No influence of
vitamin E supplementation on BMD of the lumbar and femoral neck
(FN) has also been reported in postmenopausal women [178].

Conclusions
In summary, among the water soluble vitamins, research supports
that vitamin C was most beneficial to bone. This may be because it is
a potent anti-oxidant and can help in osteoblast differentiation. Of
the different B vitamins, riboflavin, B6, biotin, folic acid and B12 had
a positive influence on bone metabolism. This may be by different
mechanism such as: inhibition of osteoclastogenesis by decreasing
in IGF-I levels, and interfering with the cross linking of proteins.
Combination of B vitamins like folic acid, B12 and B6 is probably more
effective in inhibiting the action of hyperhomocysteinemia. However,
vitamins B3 had a negative effect on bone because of their pro oxidative
effects. Of the fat soluble vitamins, vitamin K and E influenced bone
formation positively, while vitamin A has been reported to have
more deleterious effects on bone especially when given in high
concentrations during infancy and childhood. So far, based on the
available literature, after vitamin D, vitamin K supplementation
is the most promising. Vitamin K in combination with several
bisphosphonates increased BMD and strength of long bones. Further
studies should be conducted to see if vitamin K can maintain bone
mass with decreased concentrations of bisphosphonates. This will
reduce the side effects of bisphosphonates considerably. Moreover,
as pretreatment with vitamin K before bisphosphonates improves
the strength, BMC and BMD, it may also benefit individuals after
withdrawal of bisphosphonate treatment. Vitamin K may also help
diabetic patients, where the matrix is compromised. However,
more detailed studies on the effects of various vitamins have to be
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conducted to elucidate the actual benefits of the different vitamins
in maintaining bone health. The concise effects of vitamins are
summarized in Figure 1.

15. Tang K, Sham H, Hui E, Kirkland JB. Niacin deficiency causes oxidative
stress in rat bone marrow cells but not through decreased NADPH or
glutathione status. The Journal of nutritional biochemistry. 2008; 19: 746753.

An important fact to note is that most of the studies reporting
the effects of vitamins in humans are self reporting surveys. A
better understanding of the benefits of vitamins may be obtained by
interventional controlled studies. It is also important to remember
that each vitamin has a recommended intake, which should be taken
into consideration to decrease any undesirable side effects and may
help maintaining healthy bones. But most importantly, interactions
of drugs and other nutrients with vitamins should be carefully studied
before any vitamin supplementation is taken.

16. Huang PH, Lin CP, Wang CH, Chiang CH, Tsai HY, Chen JS, et al.
Niacin improves ischemia-induced neovascularization in diabetic mice
by enhancement of endothelial progenitor cell functions independent of
changes in plasma lipids. Angiogenesis. 2012; 15: 377-389.
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